There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:CS1 maint: Explicit use of et al.
Jump to navigation
Jump to search
Pages in category "CS1 maint: Explicit use of et al."
The following 200 pages are in this category, out of 8,297 total.
(previous page) (next page)2
- 2-Arachidonyl glyceryl ether
- 2-deoxyglucose-6-phosphatase
- 2-Hydroxyglutaric aciduria
- 20-hydroxyecdysone
- 21-hydroxylase deficiency epidemiology and demographics
- 21-hydroxylase deficiency history and symptoms
- 21-hydroxylase deficiency medical therapy
- 21-hydroxylase deficiency surgery
- 22q11.2 deletion syndrome history and symptoms
- 22q11.2 deletion syndrome medical therapy
4
A
- A1 receptor
- AAAS (gene)
- Aarskog-Scott syndrome
- Abatacept
- ABCC2
- ABCD syndrome
- Abdominal aortic aneurysm medical therapy
- Abdominal aortic aneurysm natural history
- Abdominal aortic aneurysm natural history, complications and prognosis
- Abdominal aortic aneurysm pathophysiology
- Abdominal aortic aneurysm physical examination
- Abdominal aortic aneurysm risk factors
- Abdominal aortic aneurysm screening
- Abdominal bruit causes
- Abdominal parasitic infection
- Abetalipoproteinemia
- Abnormalities in micturition
- AC regimen
- Acatalasemia
- ACC AHA guidelines for evaluation of unoperated patients with atrial septal defects
- ACC AHA recommendations for evaluation of the unoperated patient in atrial septal defect
- ACC/AHA recommendations for closure of patent ductus arteriosus
- ACC/AHA recommendations for evaluation of patients with unoperated patent ductus arteriosus
- ACC/AHA recommendations for reproduction in dextro-transposition of the great arteries
- ACC/AHA recommendations for reproduction in levo-transposition of the great arteries
- ACC/AHA recommendations for surgical intervention in L-transposition of the great arteries
- ACCN1
- ACCN2
- ACCN3
- Accommodative insufficiency
- ACCP guidelines classification scheme
- Acebutolol
- Aceclidine
- Acetylsalicylic acid
- ACF (gene)
- ACG guidelines classification scheme
- Achalasia epidemiology and demographics
- Achalasia pathophysiology
- Achalasia risk factors
- Achalasia surgery
- Achalasia-addisonian syndrome
- ACHE
- Acheiropodia
- Achlorhydria causes
- Achromatopsia
- Achromobacter xylosoxidans
- Acinic cell carcinoma causes
- Acinic cell carcinoma risk factors
- Acitretin
- Aclarubicin
- ACLS core cases
- Acoustic radiation astronomy
- Acral necrosis
- Acridine carboxamide
- Acrocyanosis causes
- Acromegaly differential diagnosis
- Acromegaly epidemiology and demographics
- Acromegaly historical perspective
- Acromegaly laboratory findings
- Acromegaly medical therapy
- Acromegaly natural history, complications and prognosis
- Acromegaly pathophysiology
- Acromegaly physical examination
- Acromegaly surgery
- Acromegaly x ray
- Acrydite
- ACTA1
- Actinic granuloma
- Actinin, alpha 2
- Actinomycetoma
- Action To Control Cardiovascular Risk In Diabetes
- Activated protein C resistance
- ACTN1
- ACTN3 (gene)
- Acupuncture
- Acute bloody diarrhea differential diagnosis
- Acute coronary syndrome initial management
- Acute coronary syndrome risk stratification
- Acute diarrhea and abdominal pain differential diagnosis
- Acute diarrhea and fever differential diagnosis
- Acute diarrhea and weight loss differential diagnosis
- Acute diarrhea differential diagnosis
- Acute diarrhea laboratory findings
- Acute diarrhea medical therapy
- Acute diarrhea natural history, complications and prognosis
- Acute diarrhea resident survival guide
- Acute diarrhea, abdominal pain, and weight loss differential diagnosis
- Acute diarrhea, fever, and abdominal pain differential diagnosis
- Acute fatty diarrhea differential diagnosis
- Acute intermittent porphyria
- Acute kidney injury classification
- Acute kidney injury diagnostic study of choice
- Acute kidney injury medical therapy
- Acute kidney injury natural history, complications and prognosis
- Acute kidney injury overview
- Acute kidney injury risk factors
- Acute liver failure CT
- Acute liver failure diagnostic study of choice
- Acute liver failure differential diagnosis
- Acute liver failure echocardiography or ultrasound
- Acute liver failure epidemiology and demographics
- Acute liver failure historical perspective
- Acute liver failure medical therapy
- Acute liver failure natural history, complications and prognosis
- Acute liver failure secondary prevention
- Acute lymphoblastic leukemia CT
- Acute lymphoblastic leukemia echocardiography and ultrasound
- Acute lymphoblastic leukemia historical perspective
- Acute lymphoblastic leukemia laboratory findings
- Acute lymphoblastic leukemia MRI
- Acute lymphoblastic leukemia natural history, complications and prognosis
- Acute lymphoblastic leukemia other diagnostic studies
- Acute lymphoblastic leukemia other imaging findings
- Acute lymphoblastic leukemia pathophysiology
- Acute lymphoblastic leukemia physical examination
- Acute lymphoblastic leukemia risk factors
- Acute lymphoblastic leukemia x ray
- Acute megakaryoblastic leukemia pathophysiology
- Acute mesenteric ischemia pathophysiology
- Acute mitral regurgitation treatment
- Acute muscle soreness
- Acute myeloblastic leukemia with maturation
- Acute myeloid leukemia causes
- Acute myeloid leukemia chest x ray
- Acute myeloid leukemia classification
- Acute myeloid leukemia cost-effectiveness of therapy
- Acute myeloid leukemia CT
- Acute myeloid leukemia echocardiograph and ultrasound
- Acute myeloid leukemia electrocardiogram
- Acute myeloid leukemia historical perspective
- Acute myeloid leukemia medical therapy
- Acute myeloid leukemia natural history
- Acute myeloid leukemia other diagnostic studies
- Acute myeloid leukemia physical examination
- Acute myeloid leukemia risk factors
- Acute myelomonocytic leukemia
- Acute pancreatitis causes
- Acute pancreatitis epidemiology and demographics
- Acute pancreatitis history and symptoms
- Acute pancreatitis MRI
- Acute pancreatitis natural history, complications and prognosis
- Acute pancreatitis pathophysiology
- Acute pancreatitis secondary prevention
- Acute pancreatitis surgery
- Acute promyelocytic leukemia causes
- Acute promyelocytic leukemia classification
- Acute promyelocytic leukemia cost-effectiveness of therapy
- Acute promyelocytic leukemia differential diagnosis
- Acute promyelocytic leukemia future or investigational therapies
- Acute promyelocytic leukemia historical perspective
- Acute promyelocytic leukemia medical therapy
- Acute promyelocytic leukemia natural history, complications and prognosis
- Acute promyelocytic leukemia other diagnostic studies
- Acute promyelocytic leukemia other imaging studies
- Acute promyelocytic leukemia risk factors
- Acute renal failure classification
- Acute renal failure definition
- Acute renal failure medical therapy
- Acute respiratory distress syndrome causes
- Acute respiratory distress syndrome cost-effectiveness of therapy
- Acute respiratory distress syndrome diagnostic criteria
- Acute respiratory distress syndrome diagnostic study of choice
- Acute respiratory distress syndrome epidemiology and demographics
- Acute respiratory distress syndrome future or investigational therapies
- Acute respiratory distress syndrome mechanical ventilation therapy
- Acute respiratory distress syndrome medical therapy
- Acute respiratory distress syndrome natural history, complications, and prognosis
- Acute respiratory distress syndrome overview
- Acute respiratory distress syndrome pathophysiology
- Acute respiratory distress syndrome risk factors
- Acute stress disorder differential diagnosis
- Acute stress disorder history and symptoms
- Acute stress disorder natural history, complications and prognosis
- Acute watery diarrhea differential diagnosis
- ACVBP-R regimen
- ADAM protein
- Adamantane
- Adaptive immune system
- Adenocarcinoma of the lung causes
- Adenocarcinoma of the lung differential diagnosis
- Adenocarcinoma of the lung epidemiology and demographics
- Adenocarcinoma of the lung pathophysiology
- Adenoiditis classification
Media in category "CS1 maint: Explicit use of et al."
The following 3 files are in this category, out of 3 total.
-
Aldose reductase 1us0.png 1,000 × 878; 499 KB
-
ARISE Trial - lactate values.png 467 × 272; 9 KB
-
Table LDL goal.png 960 × 720; 4 KB
